Intestinal Dysbiosis and Rheumatoid Arthritis: A Link between Gut Microbiota and the Pathogenesis of Rheumatoid Arthritis

Journal of Immunology Research

Volumn 2017, Issue , 2017, Pages

  Horta Baas, Gabriel ^a   Romero Figueroa, María Del Socorro ^a   Montiel Jarquín, Alvaro José ^a   Pizano Zárate, María Luisa ^b   García Mena, Jaime ^c   Ramírez Durán, Ninfa ^d  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b SECRETARÍA DE SALUD   (Mexico)

^c DEPARTAMENTO DE FÍSICA   (Mexico)

^d UNIVERSIDAD AUTÓNOMA DEL ESTADO DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNITY; DYSBIOSIS; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; INTESTINE FLORA; NONHUMAN; REVIEW; RHEUMATOID ARTHRITIS; ANIMAL; IMMUNOLOGY; INFLAMMATION; INTESTINE; MICROBIOLOGY;

ANIMALS; ARTHRITIS, RHEUMATOID; AUTOIMMUNITY; DYSBIOSIS; GASTROINTESTINAL MICROBIOME; HUMANS; INFLAMMATION; INTESTINES;

EID: 85029802280     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2017/4835189     Document Type: Review

References (89)

1. V. Malmstrom, A. I. Catrina, and L. Klareskog, "The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting," Nature Reviews Immunology, vol. 17, no. 1, pp. 60-75, 2017.
2. V. Taneja, "Cytokines pre-determined by genetic factors are involved in pathogenesis of rheumatoid arthritis," Cytokine, vol. 75, no. 2, pp. 216-221, 2014.
3. L. R. Espinoza and I. Garcia-Valladares, "Of bugs and joints: the relationship between infection and joints," Reumatología Clínica, vol. 9, no. 4, pp. 229-238, 2013.
4. I. Fung, J. P. Garrett, A. Shahane, and M. Kwan, "Do bugs control our fate? The influence of the microbiome on autoimmunity," Current Allergy and Asthma Reports, vol. 12, no. 6, pp. 511-519, 2012.
5. X. Zhang, D. Zhang, H. Jia et al., "The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment," Nature Medicine, vol. 21, no. 8, pp. 895-905, 2015.
6. A. K. Rodríguez-Elías, K. Maldonado-Murrillo, L. F. López-Mendoza, and J. Ramírez-Bello, "Genética y genómica en artritis reumatoide (AR): una actualización," Gaceta Médica de México, vol. 152, no. 2, pp. 218-227, 2016.
7. W. X. Liu, Y. Jiang, Q. X. Hu, and X. B. You, "HLA-DRB1 shared epitope allele polymorphisms and rheumatoid arthritis: a systemic review and meta-analysis," Clinical and Investigative Medicine, vol. 39, no. 6, pp. E182-E203, 2016.
8. H. Furukawa, S. Oka, K. Shimada, A. Hashimoto, and S. Tohma, "Human leukocyte antigen polymorphisms and personalized medicine for rheumatoid arthritis," Journal of Human Genetics, vol. 60, no. 11, pp. 691-696, 2015.
9. S. Ling, E. N. Cline, T. S. Haug, D. A. Fox, and J. Holoshitz, "Citrullinated calreticulin potentiates rheumatoid arthritis shared epitope signaling," Arthritis and Rheumatism, vol. 65, no. 3, pp. 618-626, 2013.
10. F. Pratesi, E. Petit Teixeira, J. Sidney et al., "HLA shared epitope and ACPA: just a marker or an active player?," Autoimmunity Reviews, vol. 12, no. 12, pp. 1182-1187, 2013.
11. D. Luckey, A. Gomez, J. Murray, B. White, and V. Taneja, "Bugs & us: the role of the gut in autoimmunity," The Indian Journal of Medical Research, vol. 138, no. 5, pp. 732-743, 2013.
12. A. A. Lopez-Cepero and C. Palacios, "Association of the intestinal microbiota and obesity," Puerto Rico Health Sciences Journal, vol. 34, no. 2, pp. 60-64, 2015.
13. V. Taneja, "Arthritis susceptibility and the gut microbiome," FEBS Letters, vol. 588, no. 22, pp. 4244-4249, 2014.
14. C. Ubeda and E. G. Pamer, "Antibiotics, microbiota, and immune defense," Trends in Immunology, vol. 33, no. 9, pp. 459-466, 2012.
15. M. C. Cenit-Laguna, "Rápidos avances en conocimiento sobre el papel del microbioma intestinal en salud y enfermedad," Cuadernos de Autoinmunidad, vol. 1, pp. 3-7, 2015.
16. J. Vaahtovuo, E. Munukka, M. Korkeamaki, R. Luukkainen, and P. Toivanen, "Fecal microbiota in early rheumatoid arthritis," The Journal of Rheumatology, vol. 35, pp. 1500-1505, 2008.
17. N. J. Bernard, "Rheumatoid arthritis: Prevotella copri associated with new-onset untreated RA," Nature Reviews Rheumatology, vol. 10, p. 2, 2014.
18. J. U. Scher, A. Sczesnak, R. S. Longman et al., "Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis," eLife, vol. 2, article e01202, 2013.
19. L. Skoldstam, L. Hagfors, and G. Johansson, "An experimental study of a Mediterranean diet intervention for patients with rheumatoid arthritis," Annals of the Rheumatic Diseases, vol. 62, pp. 208-214, 2003.
20. C. J. Edwards, "Commensal gut bacteria and the etiopathogenesis of rheumatoid arthritis," The Journal of Rheumatology, vol. 35, pp. 1477-14797, 2008.
21. M. Ogrendik, "Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received diseasemodifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial," Clinical Therapeutics, vol. 31, pp. 1754-1764, 2009.
22. M. Ogrendik and N. Karagoz, "Treatment of rheumatoid arthritis with roxithromycin: a randomized trial," Postgraduate Medicine, vol. 123, pp. 220-227, 2011.
23. M. Stone, P. R. Fortin, C. Pacheco-Tena, and R. D. Inman, "Should tetracycline treatment be used more extensively for rheumatoid arthritis? Metaanalysis demonstrates clinical benefit with reduction in disease activity," The Journal of Rheumatology, vol. 30, pp. 2112-2122, 2003.
24. K. D. Deane and H. El-Gabalawy, "Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE," Nature Reviews Rheumatology, vol. 10, pp. 212-228, 2014.
25. L. Lourido, F. J. Blanco, and C. Ruiz-Romero, "Defining the proteomic landscape of rheumatoid arthritis: progress and prospective clinical applications," Expert Review of Proteomics, vol. 14, pp. 431-444, 2017.
26. R. Sanmartí and J. A. Gómez-Puerta, "Biomarcadores en la artritis reumatoide," Reumatología Clínica, vol. 6, 3, pp. S25-S28, 2011.
27. N. Lee and W. U. Kim, "Microbiota in T-cell homeostasis and inflammatory diseases," Experimental & Molecular Medicine, vol. 49, article e340, 2017.
28. J. U. Scher and S. B. Abramson, "The microbiome and rheumatoid arthritis," Nature Reviews Rheumatology, vol. 7, pp. 569-578, 2011.
29. I. B. McInnes and G. Schett, "The pathogenesis of rheumatoid arthritis," The New England Journal of Medicine, vol. 365, pp. 2205-2219, 2011.
30. L. Klareskog, K. Amara, and V. Malmstrom, "Adaptive immunity in rheumatoid arthritis: anticitrulline and other antibodies in the pathogenesis of rheumatoid arthritis," Current Opinion in Rheumatology, vol. 26, pp. 72-79, 2014.
31. A. I. Catrina, V. Joshua, L. Klareskog, and V. Malmstrom, "Mechanisms involved in triggering rheumatoid arthritis," Immunological Reviews, vol. 269, pp. 162-174, 2016.
32. L. A. van de Stadt, M. H. de Koning, R. J. van de Stadt et al., "Development of the anti-citrullinated protein antibody repertoire prior to the onset of rheumatoid arthritis," Arthritis and Rheumatism, vol. 63, pp. 3226-3233, 2011.
33. J. Sokolove, R. Bromberg, K. D. Deane et al., "Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis," PLoS One, vol. 7, article e35296, 2012.
34. J. S. Smolen, D. Aletaha, and I. B. McInnes, "Rheumatoid arthritis," Lancet, vol. 388, pp. 2023-2038, 2016.
35. V. M. Holers, "Autoimmunity to citrullinated proteins and the initiation of rheumatoid arthritis," Current Opinion in Immunology, vol. 25, pp. 728-735, 2013.
36. N. Torow, B. J. Marsland, M. W. Hornef, and E. S. Gollwitzer, "Neonatal mucosal immunology," Mucosal Immunology, vol. 10, pp. 5-17, 2017.
37. J. Lee, V. Taneja, and R. Vassallo, "Cigarette smoking and inflammation: cellular and molecular mechanisms," Journal of Dental Research, vol. 91, pp. 142-149, 2012.
38. J. Versalovic, "The human microbiome and probiotics: implications for pediatrics," Annals of Nutrition & Metabolism, vol. 63, Supplement 2, pp. 42-52, 2013.
39. J. Chow, H. Tang, and S. K. Mazmanian, "Pathobionts of the gastrointestinal microbiota and inflammatory disease," Current Opinion in Immunology, vol. 23, pp. 473-480, 2011.
40. W. A. Walker, "Initial intestinal colonization in the human infant and immune homeostasis," Annals of Nutrition & Metabolism, vol. 63, Supplement 2, pp. 8-15, 2013.
41. D. Kim, M. Y. Zeng, and G. Nunez, "The interplay between host immune cells and gut microbiota in chronic inflammatory diseases," Experimental & Molecular Medicine, vol. 49, article e339, 2017.
42. C. A. Hitchon and H. S. El-Gabalawy, "Infection and rheumatoid arthritis: still an open question," Current Opinion in Rheumatology, vol. 23, pp. 352-357, 2011.
43. T. B. Bennike, T. Ellingsen, H. Glerup et al., "Proteome analysis of rheumatoid arthritis gut mucosa," Journal of Proteome Research, vol. 16, pp. 346-354, 2017.
44. K. Honda and D. R. Littman, "The microbiota in adaptive immune homeostasis and disease," Nature, vol. 535, pp. 75-84, 2016.
45. K. E. Block, Z. Zheng, A. L. Dent, B. L. Kee, and H. Huang, "Gut microbiota regulates K/BxN autoimmune arthritis through follicular helper T but not Th17 cells," Journal of Immunology, vol. 196, pp. 1550-1557, 2016.
46. F. Teng, C. N. Klinger, K. M. Felix et al., "Gut microbiota drive autoimmune arthritis by promoting differentiation and migration of Peyer's patch T follicular helper cells," Immunity, vol. 44, pp. 875-888, 2016.
47. S. Onuora, "TFH cells link gut microbiota and arthritis," Nature Reviews Rheumatology, vol. 12, p. 133, 2016.
48. G. S. Firestein and I. B. McInnes, "Immunopathogenesis of rheumatoid arthritis," Immunity, vol. 46, pp. 183-196, 2017.
49. J. U. Scher, V. Joshua, A. Artacho et al., "The lung microbiota in early rheumatoid arthritis and autoimmunity," Microbiome, vol. 4, p. 60, 2016.
50. L. I. Sakkas, D. P. Bogdanos, C. Katsiari, and C. D. Platsoucas, "Anti-citrullinated peptides as autoantigens in rheumatoid arthritis-relevance to treatment," Autoimmunity Reviews, vol. 13, pp. 1114-1120, 2014.
51. J. M. Larsen, "The immune response to Prevotella bacteria in chronic inflammatory disease," Immunology, vol. 151, 2017.
52. M. K. Bedaiwi and R. D. Inman, "Microbiome and probiotics: link to arthritis," Current Opinion in Rheumatology, vol. 26, pp. 410-415, 2014.
53. N. S. Jakubovics, "A new association for the oral metagenome," Oral Diseases, vol. 22, pp. 77-80, 2016.
54. S. G. de Aquino, S. Abdollahi-Roodsaz, M. I. Koenders et al., "Periodontal pathogens directly promote autoimmune experimental arthritis by inducing a TLR2-and IL-1-driven Th17 response," Journal of Immunology, vol. 192, pp. 4103-4111, 2014.
55. J. Chen, K. Wright, J. M. Davis et al., "An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis," Genome Medicine, vol. 8, p. 43, 2016.
56. X. Liu, Q. Zou, B. Zeng, Y. Fang, and H. Wei, "Analysis of fecal Lactobacillus community structure in patients with early rheumatoid arthritis," Current Microbiology, vol. 67, pp. 170-176, 2013.
57. P. Toivanen, S. Vartiainen, J. Jalava et al., "Intestinal anaerobic bacteria in early rheumatoid arthritis (RA)," Arthritis Research, vol. 4, p. 5, 2002.
58. U. M. Gumá, "Modelos Animales en la artritis reumatoide," Reumatología Clínica, vol. 4, pp. 129-131, 2008.
59. M. F. van den Broek, "Streptococcal cell wall-induced polyarthritis in the rat. Mechanisms for chronicity and regulation of susceptibility," Acta Pathologica, Microbiologica et Immunologica Scandinavica, vol. 97, pp. 861-878, 1989.
60. T. J. Lehman, J. B. Allen, P. H. Plotz, and R. L. Wilder, "Polyarthritis in rats following the systemic injection of Lactobacillus casei cell walls in aqueous suspension," Arthritis and Rheumatism, vol. 26, pp. 1259-1265, 1983.
61. W. J. Cromartie, J. G. Craddock, J. H. Schwab, S. K. Anderle, and C. H. Yang, "Arthritis in rats after systemic injection of streptococcal cells or cell walls," The Journal of Experimental Medicine, vol. 146, pp. 1585-1602, 1977.
62. A. Doube and A. J. Collins, "Is the gut intrinsically abnormal in rheumatoid arthritis?," Annals of the Rheumatic Diseases, vol. 47, pp. 617-619, 1988.
63. Y. Maeda, T. Kurakawa, E. Umemoto et al., "Dysbiosis contributes to arthritis development via activation of autoreactive T cells in the intestine," Arthritis & Rhematology, vol. 68, pp. 2646-2661, 2016.
64. X. Liu, B. Zeng, J. Zhang et al., "Role of the gut microbiome in modulating arthritis progression in mice," Scientific Reports, vol. 6, article 30594, 2016.
65. S. Abdollahi-Roodsaz, L. A. Joosten, M. I. Koenders et al., "Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis," The Journal of Clinical Investigation, vol. 118, pp. 205-216, 2008.
66. H. J. Wu, I. I. Ivanov, J. Darce et al., "Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells," Immunity, vol. 32, pp. 815-827, 2010.
67. S. Negi, H. Singh, and A. Mukhopadhyay, "Gut bacterial peptides with autoimmunity potential as environmental trigger for late onset complex diseases: in-silico study," PLoS One, vol. 12, article e0180518, 2017.
68. A. Gomez, D. Luckey, C. J. Yeoman et al., "Loss of sex and age driven differences in the gut microbiome characterize arthritis-susceptible 0401 mice but not arthritis-resistant 0402 mice," PLoS One, vol. 7, article e36095, 2012.
69. E. Eerola, T. Mottonen, P. Hannonen et al., "Intestinal flora in early rheumatoid arthritis," British Journal of Rheumatology, vol. 33, pp. 1030-1038, 1994.
70. R. Shinebaum, V. C. Neumann, E. M. Cooke, and V. Wright, "Comparison of faecal florae in patients with rheumatoid arthritis and controls," British Journal of Rheumatology, vol. 26, pp. 329-333, 1987.
71. M. M. Newkirk, A. Zbar, M. Baron, and A. R. Manges, "Distinct bacterial colonization patterns of Escherichia coli subtypes associate with rheumatoid factor status in early inflammatory arthritis," Rheumatology (Oxford, England), vol. 49, pp. 1311-1316, 2010.
72. A. Pianta, S. Arvikar, K. Strle et al., "Evidence of the immune relevance of Prevotella copri, a gut microbe, in patients with rheumatoid arthritis," Arthritis & Rhematology, vol. 69, pp. 964-975, 2017.
73. A. Pianta, S. L. Arvikar, K. Strle et al., "Two rheumatoid arthritis-specific autoantigens correlate microbial immunity with autoimmune responses in joints," The Journal of Clinical Investigation, vol. 127, 2017.
74. D. Kim and W. U. Kim, "Editorial: can Prevotella copri be a causative pathobiont in rheumatoid arthritis?," Arthritis & Rhematology, vol. 68, pp. 2565-2567, 2016.
75. R. E. Ley, "Gut microbiota in 2015: Prevotella in the gut: choose carefully," Nature Reviews Gastroenterology & Hepatology, vol. 13, pp. 69-70, 2016.
76. E. V. Marietta, J. A. Murray, D. H. Luckey et al., "Suppression of inflammatory arthritis by human gut-derived Prevotella histicola in humanized mice," Arthritis & Rhematology, vol. 68, pp. 2878-2888, 2016.
77. J. Zimmer, B. Lange, J. S. Frick et al., "Avegan or vegetarian diet substantially alters the human colonic faecal microbiota," European Journal of Clinical Nutrition, vol. 66, pp. 53-60, 2012.
78. P. Toivanen and E. Eerola, "A vegan diet changes the intestinal flora," Rheumatology (Oxford, England), vol. 41, pp. 950-951, 2002.
79. M. Haugen, D. Fraser, and O. Forre, "Diet therapy for the patient with rheumatoid arthritis?," Rheumatology (Oxford, England), vol. 38, pp. 1039-1044, 1999.
80. S. Bengmark, "Gut microbiota, immune development and function," Pharmacological Research, vol. 69, pp. 87-113, 2013.
81. P. Sarzi-Puttini, D. Comi, L. Boccassini et al., "Diet therapy for rheumatoid arthritis. A controlled double-blind study of two different dietary regimens," Scandinavian Journal of Rheumatology, vol. 29, pp. 302-307, 2000.
82. K. M. Maslowski and C. R. Mackay, "Diet, gut microbiota and immune responses," Nature Immunology, vol. 12, pp. 5-9, 2011.
83. H. Pan, R. Li, T. Li, J. Wang, and L. Liu, "Whether probiotic supplementation benefits rheumatoid arthritis patients: a systematyc review and meta-analysis," Engineering, vol. 3, pp. 115-121, 2017.
84. B. Alipour, A. Homayouni-Rad, E. Vaghef-Mehrabany et al., "Effects of Lactobacillus casei supplementation on disease activity and inflammatory cytokines in rheumatoid arthritis patients: a randomized double-blind clinical trial," International Journal of Rheumatic Diseases, vol. 17, pp. 519-527, 2014.
85. E. Vaghef-Mehrabany, B. Alipour, A. Homayouni-Rad, S. K. Sharif, M. Asghari-Jafarabadi, and S. Zavvari, "Probiotic supplementation improves inflammatory status in patients with rheumatoid arthritis," Nutrition, vol. 30, pp. 430-435, 2014.
86. L. Pineda Mde, S. F. Thompson, K. Summers, F. de Leon, J. Pope, and G. Reid, "A randomized, double-blinded, placebocontrolled pilot study of probiotics in active rheumatoid arthritis," Medical Science Monitor, vol. 17, pp. CR347-CR354, 2011.
87. K. D. Deane, "Rheumatoid arthritis: autoantibodies, citrullinated histones and initiation of synovitis," Nature Reviews Rheumatology, vol. 11, pp. 688-689, 2015.
88. W. Jia, H. Li, L. Zhao, and J. K. Nicholson, "Gut microbiota: a potential new territory for drug targeting," Nature Reviews Drug Discovery, vol. 7, pp. 123-129, 2008.
89. K. Hatakka, J. Martio, M. Korpela et al., "Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis-a pilot study," Scandinavian Journal of Rheumatology, vol. 32, pp. 211-215, 2003.